A Study of BMS-986249 Alone and in Combination With Nivolumab in Advanced Solid Tumors
Clinical trial NCT03369223 · COMPLETED
Trial details
- NCT number
- NCT03369223
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-06
- Primary completion
- 2024-11-07
- Enrollment
- 356
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.